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Abstract: 
In many organisms, the circadian clock is composed of functionally coupled morning and 
evening oscillators. In Arabidopsis, oscillator coupling relies on a core loop in which the evening 
oscillator component TOC1 (TIMING OF CAB EXPRESSION1) was proposed to activate a 
subset of morning-expressed oscillator genes. Here we show that TOC1 does not function as an 
activator but as a general repressor of oscillator gene expression. Repression occurs through 
TOC1 rhythmic association to the promoters of the oscillator genes. Hormone-dependent 
induction of TOC1 and analysis of RNAi plants show that TOC1 prevents the activation of 
morning-expressed genes at night. Our study overturns the prevailing model of the Arabidopsis 
circadian clock showing that the morning and evening oscillator loops are connected through the 
repressing activity of TOC1. 
 
One Sentence Summary: The morning and evening feedback loops at the core of the 




The molecular circuitry underlying circadian rhythms relies on the reciprocal regulation 
of clock components forming negative feedback loops at the core of the oscillator (1). However, 
deciphering the oscillator transcriptional regulatory code is a major challenge due to the interplay 
among clock activators and repressors, which are responsible for the generation of the loops. In 
Arabidopsis, two MYB transcription factors, CIRCADIAN CLOCK ASSOCIATED 1 (CCA1) 
and LATE ELONGATED HYPOCOTYL (LHY) (2, 3) together with the pseudo-response 
regulators PRR5, 7 and 9 (4) function as key components of a so-called morning loop, which 
interlocks with an evening loop (5, 6) composed of TOC1 (or PRR1) (4, 7), GIGANTEA (GI) (8, 
9) and a hypothetical component Y (10). The evening loop also includes the Evening Complex 
(EC) composed of EARLY FLOWERING 3 (ELF3), 4 (ELF4) and LUX ARRHYTHMO (LUX) 
(11, 12). 
Regulation of TOC1 rhythmic expression is essential for proper functioning of the clock 
(13, 14). Mechanisms that contribute to this regulation include changes in chromatin structure 
(15), transcriptional regulation (16) and protein degradation (17). Alterations of this regulation 
affect clock function and result in disrupted circadian gene expression and changes in time to 
flower (7, 18, 19). TOC1 also connects environmental signals with clock-controlled photo-
morphogenic and hormonal outputs (18, 20). Gene expression analysis using toc1 mutant plants 
led to the hypothesis that TOC1 inhibits its expression by activating the repressors CCA1 and 
LHY (16, 21). The direct interaction of TOC1 with CCA1 HIKING EXPEDITION (CHE) was 
proposed as a regulatory link connecting TOC1 with the activation of CCA1 (21). Our study 
changes the sign of TOC1 function at the core of the clock and shows that the morning and 
evening feedback loops are connected through the repressing activity of TOC1. 
We used chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) to 
obtain a high-resolution map of TOC1 chromatin occupancy on a genome-wide scale (22). The 
ChIP experiments were performed with TOC1 Minigene (TMG) seedlings expressing the 
genomic fragment of TOC1 fused to the Yellow Fluorescent Protein (18) in the  toc1-2  
(hypomorphic mutant) background (7) (fig. S1). ChIP-Seq data analysis in search for genes that 
contained one or more TOC1 binding regions identified 867 peak-to-gene associations (ChIP-
Seq peak p-value≤0.001) corresponding to 772 potential TOC1 target genes (Supporting Online 
Material, table S1 and fig. S2). Consistent with previous studies (20, 21), we found that CCA1 
and ABAR/CHLH/GUN5, binding targets of TOC1, were present in our gene list. The ABAR 
circadian expression is repressed by TOC1 (20). 
As TOC1 is a key component of the Arabidopsis circadian system, we analyzed the 
proportion of TOC1-binding genes that were under the control of the circadian clock. Using 
different circadian gene expression datasets (23, 24), we found that 40% of TOC1 targets were 
regulated by the circadian clock (table S1, S2, S6 and fig. S3, S4). Analysis of peak phases of 
expression revealed a phase enrichment around dawn (Fig. 1A-C, table S3), which suggests that 
TOC1 modulates clock genes expressed during the morning phase. We also found that the 
promoters of the oscillator components were occupied by TOC1. The targets included genes 
from both the morning (CCA1, LHY, PRR9, PRR7) and the evening loops (GI, TOC1, ELF4 and 
LUX) (Fig. 1D-G and table S4). We also identified other components associated to the oscillator 
such as PRR5 (13) whereas other clock-related genes more indirectly linked to the transcriptional 
regulation of the oscillator such as ZTL, FKF1 or LKP2 (13) or clock genes expressed only in 
specific tissues (e.g. PRR3) (13) were not found as putative TOC1 targets. Independent ChIP-Q-
PCR analyses showed specific amplification of the regions identified by ChIP-Seq, consistent 
with the binding of TOC1 to the promoters of the oscillator genes (fig. S5). We further validated 
our results by using TOC1 over-expressing plants (TOC1-ox), in which TOC1 is constitutively 
expressed. In these plants, TOC1 occupancy at the oscillator loci was significantly higher than 
occupancy at the promoters of genes not present in our ChIP-Seq list (fig. S5). We therefore 
report the association of TOC1 to the promoters of the morning and evening oscillator genes. 
Binding might be indirect and may require other co-factors and/or the formation of higher order 
protein complexes. 
Analysis of TOC1-bound oscillator sequences identified as significantly enriched a motif 
closely related to the GBox (named GBox-expanded) (Fig. 1H, fig. S6 and table S5). We also 
found that a motif very similar to the circadian motif, Evening Element (EE), was present in both 
morning and evening-expressed oscillator genes (named EE-like-expanded) (Fig. 1I, fig. S6). 
The EE motif was proposed to be associated with evening-expressed genes (16, 25). The motifs 
were positioned very close to the center of the TOC1-bound ChIP-Seq genomic regions (fig. S6). 
A similar positional enrichment at the peak maximum was observed when sequences of the 
circadian genes bound by TOC1 were analyzed (fig. S6). The results were consistent with a 
ChIP-Q-PCR screening of the CCA1 promoter, showing that amplicon enrichment decreased as 
the distance from the GBox and EE-like motifs increased (fig. S6).  
We next analyzed the role of the circadian clock in modulating TOC1 interaction with its 
target genes by performing ChIP assays with TMG plants synchronized under 12h light:12h dark 
cycles (LD). The results revealed a rhythmic oscillation of TOC1 binding with a peak at 
Zeitgeber Time 15 (ZT15 - 3 hours after lights off; ZT0: lights on), the proposed time of TOC1 
function (Fig. 2A-D). Similar oscillatory binding was observed in plants grown under constant 
light (LL) conditions (Fig. 2E-F) indicating a role for the circadian clock. The rhythmicity was 
abolished in TOC1-ox plants (Fig. 2G-H), suggesting that TOC1 binding is dictated by its 
protein abundance, which is under circadian regulation. These results together with the 
arrhythmic phenotypes of TOC1-ox (18) support the notion that the circadian pattern of TOC1 
binding is relevant for TOC1 function in the clock. 
We next examined oscillator gene expression in WT and TOC1-ox samples under LD 
and LL cycles. The peak expression of transcripts from the morning loop genes (PRR9, PRR7, 
CCA1 and LHY) was significantly reduced in TOC1-ox (Fig. 2I-J, fig. S7, table S7). This is 
noteworthy as TOC1 was previously assumed to be an activator of CCA1 and LHY expression 
(16). The reduced expression cannot be attributed to the activation of their known repressors 
PRR7 and PRR9, as their expression is also decreased in TOC1-ox plants. Analysis of the 
evening loop also revealed gene repression. For instance, GI and ELF4 were reduced around 
dusk (Fig. 2K-L) and plants expressing the LUX promoter fused to the LUCIFERASE 
(LUX::LUC) also displayed a reduced promoter activity particularly during the night (fig. S8). In 
the morning loop, oscillator components that are expressed at a similar phase repress each other 
expression (e.g. CCA1 and LHY) (2, 3). Our results suggest that similar regulation occurs in the 
evening loop, where TOC1 might also repress genes expressed during the night. The observed 
function of TOC1 as a repressor is not likely due to constitutive over-expression of TOC1 as we 
also observed decreased oscillator expression in TMG plants (expressing TOC1 under its own 
promoter) (Fig. 2I-L). 
To further confirm the transcriptional repressing function of TOC1, we generated 
transgenic plants expressing TOC1 fused to the GR domain of the glucocorticoid receptor (26). 
In the absence of a steroid ligand, the GR domain retains a nuclear factor in the cytoplasm but 
nuclear localization is restored in the presence of the synthetic glucocorticoid Dexamethasone 
(Dex). Treatment of TOC1-GR plants with Dex resulted in a reduction of CCA1 and GI 
expression relative to the mock-treated controls (Fig. 3A-B and fig. S9). Our analysis revealed 
statistically significant differences between TOC1-GR+Dex and the other genotypes (+/-Dex) 
(Fig. 3D-E) while no significant variations were found in WT plants in the presence or in the 
absence of Dex. We also analyzed the effects of TOC1-GR induction by Dex on CCA1::LUC 
activity. The in vivo studies were consistent with the RT-Q-PCR data and showed a clear 
reduction of CCA1::LUC luminescence in Dex treated plants (Fig. 3C). To further address the 
repressing function of TOC1, we examined CCA1 expression in TOC1-GR plants treated with 
Dex in the presence or in the absence of the protein synthesis inhibitor Cycloheximide (CHX). 
Our results showed that CCA1 expression was reduced after Dex treatment in the presence of 
CHX (Fig. 3F) indicating that CCA1 repression does not require de novo protein synthesis. We 
also utilized the previously described induction of TOC1 by the plant hormone abscisic acid 
(ABA) (20). We analyzed TOC1 induction by ABA and in parallel we examined CCA1 and 
PRR9 expression. The results showed that the induction of TOC1 was accompanied by a 
concomitant reduction of CCA1 and PRR9 expression (Fig. 3G-I). Our studies, together with the 
results of toc1 mutant plants (see Fig. 4) indicate that in contrast to its previously assigned 
activating role, TOC1 functions as a repressor of oscillator gene expression. 
The repressive function of TOC1 provides an explanation for recently published 
experimental data that cannot be reconciled with an activating role for TOC1. For instance, 
analysis of ztl mutant plants, with increased TOC1 accumulation (17), revealed a reduced 
expression of LHY and CCA1 (27), which is not consistent with TOC1 activating function. The 
data also showed low abundance of PRR9 and PRR7 expression (27). Thus, the reduced 
expression of LHY and CCA1 cannot be attributed to increased abundance of their inhibitors. To 
clarify TOC1 function in the clock, we examined oscillator gene expression in TOC1 RNAi and 
toc1-2 mutant plants grown under LD cycles. Our results showed an advanced phase for LHY 
expression at the onset of transcription (Fig. 4A and fig. S10) suggesting that the absence of 
TOC1 alleviates the repression normally observed in WT plants around dusk. The advanced 
phase of LHY expression correlated with a slight increase of PRR7 (Fig. 4B and fig. S10). These 
results suggest that TOC1 temporally extends the repressing function of the other sequentially 
expressed PRRs inhibitors (28) (Fig. 4E). The absence of TOC1 in toc1 mutant plants shortens 
the duration of this repression and as a consequence, the onset of LHY transcription is advanced 
(Fig. 4F). The effects on the trough of LHY are subtle, most likely because the expression of 
other CCA1/LHY repressors is also increased (Fig. 4C-D). In TOC1-ox, the abnormally high 
expression of TOC1 during the day reveals its repressing function at times when TOC1 is not 
normally expressed (Fig. 4G).  Altogether, our studies support the repressing function of TOC1 
on oscillator gene expression, which changes the regulatory circuit at the core of the Arabidopsis 
circadian clock (fig. S11). 
Conclusions about the circadian transcriptional networks are complicated by the 
existence of multiple feedback loops and gene redundancies. Our study shows the complex and 
dynamic function of TOC1 as a regulator of oscillator gene expression, with a repressing activity 
of the morning and evening loops. Binding of TOC1 to the promoters of the oscillator genes may 
antagonize transcriptional activation around the time of peak expression. The mechanisms of 
oscillator gene activation are largely unknown but chromatin remodelling and light-dependent 
regulation may play key roles at defined times of day. The challenge remains now to identify the 
mechanisms and components responsible for the activation of oscillator gene expression. 
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Fig. 1. Analysis of TOC1 ChIP-Seq circadian targets. Global trend of expression phases within 
TOC1 circadian targets (A, B) and for a random list of circadian genes (C). Phase enrichments 
were graphically portrayed within a range of ChIP-Seq p-values (legends) at different Zeitgeber 
Times (radial axis: 0-dawn; 12-dusk). The white and grey areas represent day and night, 
respectively. Peak traces of LHY (D), PRR7 (E) PRR9 (F) and GI (G) from TOC1 ChIP-Seq 
data. The exon-intron-UTR structure of the different gene models above and below each panel 
indicates forward and reverse orientation, respectively. Position weight matrix representation of 
consensus motifs present within the TOC1 target oscillator sequences. The Gbox-expanded (H) 
and EE-like-expanded (I) motifs were identified using the SCOPE motif finder. Both strands 
were used to compute the significance value. ChIP-Seq, peak visualization, circadian phase 
analysis and motif discovery were performed as described in Supporting Online Material. 
Fig. 2. TOC1 binds to the promoters of the oscillator genes and inhibits their expression. ChIP-
Q-PCR assays of TMG plants sampled every four hours over a 24-hour LD cycle. Primers 
encompassing target sequences obtained in the ChIP-Seq analysis were used to amplify CCA1 
and LHY (A); PRR7 and PRR9 (B), GI and PRR5 (C) or LUX/PCL1 and ELF4 (D). Binding was 
also examined under LL conditions following entrainment in TMG (E-F) and in TOC1-ox plants 
(G-H). Values are represented as means ± SEM. Expression profiling of PRR9 (I), PRR7 (J), GI 
(K) and ELF4 (L) in WT, TMG and TOC1-ox plants. Gene expression was analyzed in plants 
grown under LD cycles. mRNA abundance was normalized to IPP2 expression. Values represent 
means ± SEM. White boxes: day; grey boxes: night.  
Fig. 3. Effects of TOC1 transient induction on oscillator gene expression. Analysis of CCA1 (A) 
and GI (B) in WT and TOC1-GR plants mock-treated or treated with 5 µM dexamethasone 
(+Dex). Seedlings were treated at ZT10 and samples were analyzed at the indicated ZT. (C) 
Analysis of CCA1::LUC luminescence in TOC1-GR seedlings under 8h light:16h dark cycles. 
Luminescence was recorded 24 hours after the seedlings were transferred to medium containing 
5 µM of Dex. Data are presented as means ± SEM of luminescence signals from 6-7 independent 
plants. (D, E and F) Comparisons of CCA1 expression in TOC1-GR plants mock-treated or 
treated with 5 µM of Dex at ZT10 and analyzed at ZT21 and ZT23 in the absence (-CHX) or in 
the presence (+CHX) of 50 µM of cycloheximide. The statistical relevance of the differences is 
presented (*p-value<0.05; **p-value<0.01; ***p-value<0.001). (G, H and I) Time course 
analysis of TOC1, CCA1 and PRR9 expression over the diurnal cycle in TMG plants in the 
presence or in the absence of the hormone Abscisic Acid (ABA). Seedlings were sprayed with 
100 μM (±) ABA at ZT5. The Y axes of the CCA1 and PRR9 graphs were divided into segments 
so that repression at trough can be clearly observed. White boxes: day; grey boxes: night. 
Fig. 4. Gene expression analysis in TOC1 RNAi plants. Analysis of LHY (A) and PRR7 (B) 
expression under 12L:12D conditions. Gene expression analysis of PRR9 (C) and GI (D) during 
the night in TOC1 RNAi under 12L:12D conditions. Values are represented as means ± SEM. 
Analysis was performed as described in Supporting Online Material. Schematic diagrams 
depicting the waveform of CCA1/LHY expression and the different waves of PRRs repression. 
Schemes depict the regulations in WT (black line) (E), toc1 mutant (blue line) (F) and TOC1-ox 
(red line) (G). The small lines ending in perpendicular dashes represent repression. White boxes: 
day; black boxes: night.  
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